Beximco Pharmaceuticals Ltd. GDR Stock
The Beximco Pharmaceuticals Ltd. GDR price is unchanged compared to yesterday.
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 0.000% | 0.980% | 19.767% | 14.955% | 7.292% | -47.449% |
| Eledon Pharmaceuticals Inc. | -0.860% | 4.545% | 39.394% | -31.548% | 79.688% | 11.650% | -79.464% |
| SELLAS Life Sciences Group Inc | 7.560% | -1.677% | 55.298% | 339.962% | 65.432% | 271.485% | -45.172% |
| Grifols S.A. ADR | -2.170% | -7.534% | -10.596% | -2.174% | -11.184% | -1.460% | -48.809% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%